References
- 1. BARENDREGT PJ, VISSER MRM, SMETS EMA, TULEN JH, VAN DEN MEIRACKER AH, BOOMSMA F et al. Fatigue in primary Sjogren’s syndrome. Ann Rheum. 1998; 57: 291–5.
- 2. SWAIM M. Fatigue in chronic disease. Clin Sci. 2000; 9: 1–8.
- 3. HUYSE BAR, PARKER JC, THORESON R, SMARR KL, JOHNSON JC, HOFFMAN R. Predictors of subjective fatigue among individuals with rheumatoid arthritis. Arthritis Rheum. 1998; 41:2230–7.
- 4. WOLFE F, HAWLEY DJ, WILSON K. The prevalence and meaning of fatigue in rheumatic disease. J Rheumatol. 1996; 23:1407–17.
- 5. SUURMEIJER TP, WALTZ M, MOUM T, GUILLEMIN F, VAN SONDEREN FLP, BRIANCON S et al. Quality of life profiles in the first years of rheumatoid arthritis: results from the EURIDISS longitudinal study. Arthritis Rheum. 2001; 45:111–21.
- 6. CAMPBELL RC, BATLEY M, HAMMOND A, IBRAHIM F, KINGSLEY G, SCOTT DL. The impact of disease activity, pain, disability and treatments on fatigue in established rheumatoid arthritis. Clin Rheumatol. 2012; 31:717–22.
- 7. KINGSLEY G, SCOTT I C AND SCOTT DL. Quality of life and the outcome of established rheumatoid arthritis. Best Practice & Research Clinical Rheumatology. 2011; 25: 585–606.
- 8. HEWLETT S1, COCKSHOTT Z, BYRON M, KITCHEN K, TIPLER S, POPE D, et al. Patient’s perception of fatigue in rheumatoid arthritis: overwhelming, uncontrollable, ignored. Arthritis Rheum. 2005; 53:697–702.
- 9. HIDER SL1, TANVEER W, BROWNFIELD A, MATTEY DL, PACKHAM JC. Depression in RA patients treated with anti-TNF is common and under recognized in the rheumatology clinic. Rheumatology. 2009; 48:1152–4.
- 10. FLOWERS N, WOLFE F. What do rheumatologists do in their practices? Arthritis Rheum. 1998; 41:337.
- 11. FELSON DT, ANDERSON JJ, BOERS M, BOMBARDIER C, CHERNOFF M, FRIED B et al. The American College of Rheumatology preliminary core set of disease activity measures for rheumatoid arthritis clinical trials. The Committee on outcome measures in rheumatoid arthritis clinical trials. Arthritis Rheum. 1993; 36:729–40.
- 12. CONAGHAN PG, GREEN MJ AND EMERY P. Established rheumatoid arthritis. Baillieres Best Pract Res Clin Rheumatol. 1999; 13:561–575
- 13. VAN GESTEL, A. M., M. L. PREVOO, et al. Development and validation of the European League Against Rheumatism response criteria for rheumatoid arthritis. Comparison with the preliminary American College of Rheumatology and the World Health Organization/International League Against Rheumatism Criteria. Arthritis Rheum. 1996; 39(1): 34–40.
- 14. CELLA D,YOUNT S, SORENSEN M, CHARTASH E, SENGUPTA N, GROBER J. Validation of the Functional Assessment of Chronic Illness Therapy Fatigue Scale relative to other instrumentation in patients with rheumatoid arthritis. J Rheumatol. 2005; 32:811–9.
- 15. DETERT J, DZIURLA R, HOFF P, GABER T, KLAUS P, BASTIAN H, et al. Effects of treatment with etanercept versus methotrexate on sleep quality, fatigue and selected immune parameters in patients with active rheumatoid arthritis. Clin Exp Rheumatol 2016; 34:848–56.
- 16. GENTY M, COMBE B, KOSTINE M, ARDOUIN E, MOREL J, LUKAS C. Improvement of fatigue in patients with rheumatoid arthritis treated with biologics: relationship with sleep disorders, depression and clinical efficacy. A prospective, multicentre study. Clin Exp Rheumatol 2017; 35:85–92.
- 17. GOSSEC L, STEINBERG G, ROUANET S, COMBE B. Fatigue in rheumatoid arthritis: quantitative findings on the efficacy of tocilizumab and on factors associated with fatigue. The French multicentre prospective PEPS Study. Clin Exp Rheumatol 2015; 33:664–70.
- 18. YOUNT S, SORENSEN MV, CELLA D, SENGUPTA N, GROBER J, CHARTASH EK. Adalimumab plus methotrexate or standard therapy is more effective than methotrexate or standard therapies alone in the treatment of fatigue in patients with active, inadequately treated rheumatoid arthritis. Clin Exp Rheumatol 2007; 25:838–46.
- 19. BAE SC, GUN SC, MOK CC, KHANDKER R, NAB HW, KOENIG AS, et al. Improved health outcomes with Etanercept versus usual DMARD therapy in an Asian population with established rheumatoid arthritis. BMC Musculoskeletal Disorders. 2013; 14:13.
- 20. WOLFE F, MICHAUD K, PINCUS T. Fatigue, rheumatoid arthritis, and anti-tumor necrosis factor therapy: an investigation in 24,831 patients. J Rheumatol. 2004; 31:2115–20.
- 21. ABU-SHAKRA M, ZISMAN D, BALBIR-GURMAN A, AMITAL H, LEVY Y, LANGEVITZ P, et al. Effect of Tocilizumab on Fatigue and Bone Mineral Density in Patients with Rheumatoid Arthritis. Isr Med Assoc J IMAJ 2018; 20:239–44.
- 22. CHAUFFIER K, SALLIOT C, BERENBAUM F, SELLAM J. Effect of biotherapies on fatigue in rheumatoid arthritis: a systematic review of the literature and meta-analysis. Rheumatology. 2012; 51(1):60–8.
- 23. MORELAND LW, GENOVESE MC, SATO R, SINGH A. Effect of etanercept on fatigue in patients with recent or established rheumatoid arthritis. Arthritis Rheum. 2006; 55:287–93.
- 24. POLLARD LC, CHOY EH, GONZALEZ J, KHOSHABA B, SCOTT DL. Fatigue in rheumatoid arthritis reflects pain, not disease activity. Rheumatology (Oxford). 2006; 45:885–9.
- 25. RIGBY W1, FERRACCIOLI G, GREENWALD M, ZAZUETA-MONTIEL B, FLEISCHMANN R, WASSENBERG S, et al. Effect of Rituximab on Physical Function and Quality of Life in Patients With Rheumatoid Arthritis Previously Untreated With Methotrexate. Arthritis Care & Research. 2011; 5:711–20.
- 26. COROMINAS H, ALEGRE C, NARVAEZ J, FERNANDEZ-CID CM, TORRENTE-SEGARRA V, GOMEZ MR, et al. Correlation of fatigue with other disease related and psychosocial factors in patients with rheumatoid arthritis treated with tocilizumab: ACT-AXIS study. Medicine (Baltimore) 2019; 98:e15947.
- 27. MINNOCK P, VEALE DJ, BRESNIHAN B, FITZGERALD O, MCKEE G. Factors that influence fatigue status in patients with severe rheumatoid arthritis (RA) and good disease outcome following 6 months of TNF inhibitor therapy: a comparative analysis. Clin Rheumatol 2015; 34:1857–65.
- 28. EGSMOSE EL, MADSEN OR. Fatigue in Patients with Rheumatoid Arthritis Selected for Biological Treatment in the Daily Clinic: Associations with Classical Measures of Disease Activity. Ann Rheum Dis. 2014; 73:412–413.
- 29. LISITSYNA TA, SERAVINA O, KOVALEVSKAYA O, VELTISHCHEV D, ZELTYN A, NOVIKOVA D et al. Fatigue in rheumatoid arthritis patients: The impact of disease activity, pain, disability and depressive disorders. Ann Rheum Dis. 2013; 71:179.
- 30. DRUCE KL, JONES GT, MACFARLANE GJ, BASU N. Determining Pathways to Improvements in Fatigue in Rheumatoid Arthritis: Results From the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis. Arthritis Rheumatol. 2015; 67(9):2303–10.
- 31. ALMEIDA C, CHOY EHS, HEWLETT S, KIRWAN JR, CRAMP F, CHALDER T, et al. Biologic interventions for fatigue in rheumatoid arthritis. Cochrane Database Syst Rev 2016.
- 32. FELDTHUSEN C, GRIMBY-EKMAN A, FORSBLAD-D’ELIA H, JACOBSSON L, MANNERKORPI K. Seasonal variations in fatigue in persons with rheumatoid arthritis: a longitudinal study. BMC MusculoskeletDisord. 2016; 17:59.